From Discovery to Clinic: Getting Ready for Phase 1 20 April 2016 The Nucleus, Chesterford Research Park, Little Chesterford, Cambridge CB10 1XL
Programme 09.00
Registration and networking
09.15
Introductions Phil Berry, Catalent
09.30
Drug Substance – API development priorities: Positioning for Phase I and beyond John Knight, JKonsult
10.15
Drug Product – Early dose form selection: Selecting and optimizing formulation technologies for clinical success Pascale Clement, Catalent
11.00
Drug Product – Challenges and Solutions for Non-invasive Macromolecule Delivery Julien Meissonnier, Catalent
11.15
Coffee and networking
11:30
Regulatory – Best practices for preparing the IMPD quality section Judith Jones, Catalent
12.00
Clinical – Early clinical studies: What can we achive? Malcolm Boyce, Hammersmith Medicines Research
12.45
Networking lunch
13.15
1:1 Private Consultancy Appointments
14.00
Event closes